Notice of interim decisions to amend (or not to amend) the current Poisons Standard - ACMS/ACCS/Joint ACMS-ACCS meeting, June 2020

Overview

Scheduling amendments referred to expert advisory committee

This consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the scheduling in the Poisons Standard, following advice sought at the 23-25 June 2020 meetings of the Advisory Committee on Medicines Scheduling (ACMS), and the Advisory Committee on Chemicals Scheduling (ACCS).

All submissions received will be considered by the delegate along with advice from the Advisory Committees before they make a final decision.

The interim decisions under consultation are detailed in the Public Notice of interim decision, June 2020.

The closing date for these consultations is close of business 13 October 2020.

Note that the interim decision on nicotine is not published in this notice. Publication is planned for 23 September 2020.

Substances for which public comment is sought

• 1.1. oxymetazoline
• 1.2. eletriptan
• 1.3. clotrimazole
• 1.4. sildenafil
• 1.5. ibuprofen
• 1.6. cumyl-pegaclone
• 2.1. cannabidiol (private application) and cannabidiol (delegate initiated)

What happens next

All public submissions will be published on the TGA website at Public submissions on scheduling matters, unless marked confidential or indicated otherwise in the submission information (see Privacy and your Personal information).

Following consideration of public submissions received before the closing date and advice from the expert advisory committee/s, decisions on the proposed amendments are anticipated to be published as final decisions on the TGA website: Scheduling delegate's final decisions  in  February 2021.